Rengyun Liu

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Endocrine

Clinical and translational medicine

Cancer cell international

Oncogene

The First Affiliated Hospital of Sun Yat-sen University

Soochow University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The First Affiliated Hospital of Sun Yat-sen University Jul 23 2019

China

Professor

Johns Hopkins University School of Medicine May 01 2013 - Apr 30 2019

United States

Postdoc Fellow :: Division of Endocrinology, Diabetes and Metabolism / Medicine

Education History

Soochow University Sep 01 2009 - Jul 01 2012

China

PHD :: Medicine

Soochow University Sep 01 2006 - Jul 01 2009

China

MSC :: Medicine

Publications

Ye Sang, Guanghui Hu, Junyu Xue, Mengke Chen, Shubin Hong, Rengyun Liu
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer. Endocrine 85 (1) (2024)
Ye Sang, Guanghui Hu, Junyu Xue, Mengke Chen, Shubin Hong, Rengyun Liu
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer. Endocrine (2024)
Shiyong Li, Guanghui Hu, Yulu Chen, Ye Sang, Qin Tang, Rengyun Liu
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer. Cancer cell international 24 (1) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Ye Sang, Guanghui Hu, Junyu Xue, Mengke Chen, Shubin Hong, Rengyun Liu
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer. Endocrine 85 (1) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Ye Sang, Guanghui Hu, Junyu Xue, Mengke Chen, Shubin Hong, Rengyun Liu
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer. Endocrine 85 (1) (2024)
Shiyong Li, Guanghui Hu, Yulu Chen, Ye Sang, Qin Tang, Rengyun Liu
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer. Cancer cell international 24 (1) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing
Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Avaniyapuram Kannan Murugan, Rengyun Liu, Mingzhao Xing
Identification and characterization of two novel oncogenic mTOR mutations. Oncogene 38 (26) (2019)
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer. Nature communications 9 (1) (2018)

Rengyun Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rengyun Liu